Automating Pediatric Oncology Carelon Prior Authorizations

Klivira streamlines the complex landscape of prior authorizations for pediatric oncology with Carelon, ensuring critical treatments are approved efficiently.

Revenue cycle directors and prior authorization coordinators in pediatric oncology face unique challenges when navigating utilization management requirements from payers like Carelon. The urgency of childhood cancer treatments demands an efficient, accurate, and automated approach to prior authorization, minimizing delays for life-saving therapies.

Navigating Pediatric Oncology Prior Authorization with Carelon

Pediatric oncology involves highly specialized, often high-cost treatments governed by stringent clinical protocols and payer utilization management. Carelon, as Elevance Health's UM subsidiary, applies specific criteria to these requests. Klivira's platform is designed to integrate these payer-specific requirements directly into your workflow, reducing manual effort and improving submission accuracy for pediatric oncology cases.

Key Prior Authorization Triggers for Carelon in Pediatric Oncology

COG-protocol chemotherapy regimens, including high-dose chemotherapy with stem cell rescue.
CAR-T cell therapies and other novel cellular immunotherapies.
Proton beam radiation therapy and other advanced radiation modalities.
Specialty pharmacy medications for targeted therapies.
Advanced diagnostic imaging, such as PET/CT scans and specialized MRIs.

EMR Integration and Payer Touchpoints for Carelon Submissions

Efficient prior authorization for pediatric oncology Carelon cases requires seamless integration with your EMR (e.g., Epic, Cerner). Klivira facilitates the extraction of necessary clinical documentation—such as treatment plans, growth charts, and pathology reports—from order types like chemotherapy orders or radiology requisitions. We support submission via X12 278 transactions and ePA, connecting directly to Carelon's digital channels to reduce reliance on manual portal submissions.

Clinical Evidence and Guideline Adherence for Childhood Cancer Therapies

Carelon's utilization management decisions for pediatric oncology are informed by established clinical guidelines. Submissions must clearly demonstrate adherence to Children's Oncology Group (COG) protocols, NCCN guidelines (where applicable), and ASCO recommendations. Klivira's platform helps structure your clinical documentation to align with these evidentiary requirements, supporting a stronger case for approval.

Optimizing the Pediatric Oncology Carelon Workflow with Klivira

Klivira automates the prior authorization process for pediatric oncology Carelon requests, from initial submission to status tracking and appeals management. Our system proactively identifies missing information, leverages AI to match clinical data with payer rules, and provides real-time insights into authorization statuses. This reduces administrative burden, accelerates approval times, and ensures your team can focus on patient care.

Frequently asked questions

How does Klivira handle specific COG protocol PA requests for Carelon?

Klivira's platform is configured to recognize the unique documentation requirements for COG protocols. It helps compile and submit the necessary clinical evidence, such as specific regimen details and staging information, to Carelon via integrated ePA channels, ensuring compliance with their UM criteria.

What EMR systems does Klivira integrate with for pediatric oncology Carelon submissions?

Klivira offers robust integration capabilities with leading EMR systems like Epic and Cerner. This allows for direct data extraction from patient charts, streamlining the transfer of clinical information required for Carelon prior authorization requests in pediatric oncology.

Can Klivira help with urgent CAR-T PA requests to Carelon?

Yes, Klivira is designed to accelerate the prior authorization process, which is critical for urgent therapies like CAR-T. By automating data submission and tracking, we aim to reduce manual delays and expedite communication with Carelon, helping to secure timely approvals for these time-sensitive treatments.

How does Klivira ensure clinical documentation aligns with Carelon's requirements for peds onc?

Klivira utilizes intelligent automation to cross-reference submitted clinical documentation with Carelon's known requirements and relevant clinical guidelines for pediatric oncology. The system flags potential gaps or inconsistencies, prompting users to provide complete and accurate information before submission, enhancing the likelihood of first-pass approvals.